Officers and directors of Irish and Northern Irish companies whose products would be regulated by the US Food and Drug Administration (life sciences companies, specifically) should be aware of developments on the issue of individual prosecution under the FDCA for company violations of that statute. AGG partner Alan Minsk and associate Alex Foster have written an update that is new to AGG’s Knowledge Center. Continue reading
FDA
Webinars for Irish and Northern Irish Companies (free content, too!)
Late last year, we held a series of webinars directed to Irish and Northern Irish companies looking to do (or doing) business in the US. The webinars were well-attended, and, in part, led to the creation of this blog. We want to share those webinars, and their content, with you.
The first webinar introduced the concept of ‘smart exporting’ and provided a high-level view of some key legal issues relevant to Irish and Northern Irish companies in the US market. The presentation for this ‘smart exporting’ webinar can be found here; the recording of the webinar (requires registration) can be found here.
Irish Export Insights 